Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella).

Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella). - Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella).

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000050133

Enrollment

Registered

2023-01-30

Start date

2023-01-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consecutive cases of cardiogenic shock with the use of Impella.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Consecutive cases of cardiogenic shock using Impella during hospitalisation at Iwate Medical University Hospital in the last four years from 8 August 2018 to 31 March 2022.

Exclusion criteria

Exclusion criteria: Under 20 years of age

Design outcomes

Primary

Measure	Time frame
30-day survival	—

Countries

Japan

Contacts

Public ContactTakahito Nasu

Iwate Medical University Division of Cardiology, Department of Internal Medicine. Division of Biomedical Information Analysis

tnasu@iwate-med.ac.jp+81-019-613-7111

Outcome results